ITU Unit Action

BREYANZI

JUNO THERAPEUTICS, INC.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 88569196 FILING DATE 08/07/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY KENEALY, NATALIE LANGF
L.O. ASSIGNED 104

PUB INFORMATION

RUN DATE 04/17/2020
PUB DATE 10/22/2019
STATUS 730-FIRST EXTENSION - GRANTED
STATUS DATE 04/15/2020
LITERAL MARK ELEMENT BREYANZI

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT BREYANZI
MARK DRAWING CODE 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG YES

CURRENT OWNER INFORMATION

PARTY TYPE 21-SUBSEQUENT OWNER AFTER PUBLICATION
NAME JUNO THERAPEUTICS, INC.
ADDRESS 400 DEXTER AVENUENORTH
SUITE 1200
SEATTLE, WA 98109
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations for the treatment of cancer and auto-immune diseases; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations for inhibiting cytokine production; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, preparations for use in the treatment of tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
COLORS CLAIMED STATEMENT The color(s) dark blue, light blue, and orange is/are claimed as a feature of the mark.
DESCRIPTION OF MARK The mark consists of "BREYANZI" in dark blue font with an orange dot over the "I" with a sunburst design behind and above the "ZI" with half of the dots in the upper side in dark blue dots and the other half of the dots in the lower side in light blue dots.
OWNER OF US REG NOS 5709663   

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
04/17/2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 014
04/15/2020 EX1G S EXTENSION 1 GRANTED 013
04/15/2020 EXT1 S EXTENSION 1 FILED 012
04/15/2020 EEXT I TEAS EXTENSION RECEIVED 011
12/17/2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 010
10/30/2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP 009
10/22/2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 008
10/22/2019 PUBO A PUBLISHED FOR OPPOSITION 007
10/02/2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 006
09/17/2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 005
09/17/2019 DOCK D ASSIGNED TO EXAMINER 004
08/24/2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED 003
08/23/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
08/10/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Camille M. Miller
CORRESPONDENCE ADDRESS Camille M. Miller
COZEN O'CONNOR
1650 MARKET STREET, SUITE 2800
ONE LIBERTY PLACE
PHILADELPHIA PA 19103
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Celgene Corporation
ADDRESS 86 Morris Avenue
Summit, NJ 07901
ENTITY 03-CORPORATION
CITIZENSHIP Delaware
PARTY TYPE 10-ORIGINAL APPLICANT
NAME Celgene Corporation
ADDRESS 86 Morris Avenue
Summit, NJ 07901
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed